What's Your Experience?

APA's Office of Healthcare Systems and Financing (OHSF) is continuing to monitor the implementation of the new Medicare Part D prescription drug benefit. Information is being collected by e-mail at [email protected] and phone calls at (866) 882-6227. Currently OHSF is particularly interested in tracking how the Part D appeals system is working.

At press time, OHSF had received reports of more than 1,000 problems with the new benefit. Information from these reports is being used in regularly scheduled discussions with senior staff at the Centers for Medicare and Medicaid Services (CMS) in an effort to ensure that the Part D prescription drug plans comply with CMS's guidances on the need for continuity of care for patients being treated with antidepressants, antipsychotics, and anticonvulsants.